Yuhan Corporation (KOSE: A000100)
Health Care · Pharmaceuticals · KR
₩82,300.00
-1.67% today · -28.4% 1Y
Yuhan Corporation (KOSE: A000100) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $4.43B.
Over the last twelve months the share price has lost 28.4%, trading between 65.00K and 129.20K.
Tweenvest scores Yuhan Corporation across four factors: quality 75/100, value 58/100, growth 50/100. Its strongest factor is quality.
A000100 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.43B
- Revenue (TTM)
- $1.47B
- P/E
- 26.21
- EPS
- 3,139.61
- Dividend yield
- —
- Beta (5Y)
- 0.40
- 52-week high
- ₩129,200.00
- 52-week low
- ₩65,000.00
- Avg volume (3M)
- —
- Shares outstanding
- 74.76M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,256.11 | +0.06% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.93 | +0.63% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.78 | +0.15% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.14 | +0.25% |
Figures last refreshed Aug 18, 2026.